Research ExplorerScientific StaffFrank Jacobsen Publications

Dr.med. ID: 41002

Frank Jacobsen

graph of relations
Affiliations
51 - 100 out of 100Page size: 50

Publications

  1. 2020

  2. Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer

    Eichenauer, T., Simmendinger, L., Kluth, M., Chirico, V., Luebke, A. M., Höflmayer, D., Hinsch, A., Jacobsen, F., Hube-Magg, C., Möller-Koop, C., Dahlem, R., Fisch, M., Rink, M., Riechardt, S., Tsourlakis, M. C., Büscheck, F., Bernreuther, C., Clauditz, T., Lebok, P., Simon, R., Sauter, G., Wilczak, W. & Fraune, C., 06.2020, In: UROL ONCOL-SEMIN ORI. 38, 6, p. 605.e1-605.e8

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms

    Blessin, N. C., Spriestersbach, P., Li, W., Mandelkow, T., Dum, D., Simon, R., Hube-Magg, C., Lutz, F., Viehweger, F., Lennartz, M., Fraune, C., Nickelsen, V., Fehrle, W., Göbel, C., Weidemann, S., Clauditz, T., Lebok, P., Möller, K., Steurer, S., Izbicki, J. R., Sauter, G., Minner, S., Jacobsen, F., Luebke, A. M., Büscheck, F., Höflmayer, D., Wilczak, W., Burandt, E. & Hinsch, A., 06.2020, In: CELL ONCOL. 43, 3, p. 421-430 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinoma

    Jacobsen, F., Kohsar, J., Gebauer, F., Kluth, M., Hube-Magg, C., Simon, R., Bockhorn, M., Hinsch, A., Burandt, E., Lübke, A. M., Steurer, S., Tachezy, M., Sauter, G., Izbicki, J. R., Wilczak, W. & Melling, N., 24.03.2020, In: ONCOTARGET. 11, 12, p. 1007-1016 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. High RSF1 protein expression is an independent prognostic feature in prostate cancer

    Höflmayer, D., Hamuda, M., Schroeder, C., Hube-Magg, C., Simon, R., Göbel, C., Hinsch, A., Weidemann, S., Möller, K., Izbicki, J. R., Jacobsen, F., Mandelkow, T., Blessin, N. C., Lutz, F., Viehweger, F., Sauter, G., Burandt, E., Lebok, P., Lennartz, M., Fraune, C., Minner, S., Bonk, S., Huland, H., Graefen, M., Schlomm, T. & Büscheck, F., 03.2020, In: ACTA ONCOL. 59, 3, p. 268-273 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients

    Büscheck, F., Sulimankhil, M., Melling, N., Höflmayer, D., Hube-Magg, C., Simon, R., Göbel, C., Hinsch, A., Weidemann, S., Izbicki, J. R., Jacobsen, F., Mandelkow, T., Blessin, N. C., Möller-Koop, C., Lutz, F., Viehweger, F., Möller, K., Sauter, G., Lennartz, M., Burandt, E., Lebok, P., Minner, S., Bonk, S., Huland, H., Graefen, M., Schlomm, T. & Fraune, C., 02.2020, In: CANCER MED-US. 9, 4, p. 1409-1418 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

    Höflmayer, D., Steinhoff, A., Hube-Magg, C., Kluth, M., Simon, R., Burandt, E., Tsourlakis, M. C., Minner, S., Sauter, G., Büscheck, F., Wilczak, W., Steurer, S., Huland, H., Graefen, M., Haese, A., Heinzer, H., Schlomm, T., Jacobsen, F., Hinsch, A., Poos, A. M., Oswald, M., Rippe, K., König, R. & Schroeder, C., 01.2020, In: MOL ONCOL. 14, 1, p. 129-138 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. 2019

  9. Upregulation of SPDEF is associated with poor prognosis in prostate cancer

    Meiners, J., Schulz, K., Möller, K., Höflmayer, D., Burdelski, C., Hube-Magg, C., Simon, R., Göbel, C., Hinsch, A., Reiswich, V., Weidemann, S., Izbicki, J. R., Sauter, G., Jacobsen, F., Möller-Koop, C., Mandelkow, T., Blessin, N. C., Lutz, F., Viehweger, F., Lennartz, M., Fraune, C., Heinzer, H., Minner, S., Bonk, S., Huland, H., Graefen, M., Schlomm, T. & Büscheck, F., 11.2019, In: ONCOL LETT. 18, 5, p. 5107-5118 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer

    Lebok, P., von Hassel, A., Meiners, J., Hube-Magg, C., Simon, R., Höflmayer, D., Hinsch, A., Dum, D., Fraune, C., Göbel, C., Möller, K., Sauter, G., Jacobsen, F., Büscheck, F., Prien, K., Krech, T., Krech, R. H., von der Assen, A., Wölber, L., Witzel, I., Schmalfeldt, B., Geist, S., Paluchoswski, P., Wilke, C., Heilenkötter, U., Terracciano, L., Müller, V., Wilczak, W. & Burandt, E. C., 18.09.2019, In: AGING-US. 11, 18, p. 7796-7804 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy

    Schroeder, C., Navid-Hill, E., Meiners, J., Hube-Magg, C., Kluth, M., Makrypidi-Fraune, G., Simon, R., Büscheck, F., Luebke, A. M., Goebel, C., Lang, D. S., Weidemann, S., Neubauer, E., Hinsch, A., Jacobsen, F., Lebok, P., Michl, U., Pehrke, D., Huland, H., Graefen, M., Schlomm, T., Sauter, G. & Höflmayer, D., 13.08.2019, In: ONCOTARGET. 10, 48, p. 4973-4986 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. 5q21 deletion is often heterogeneous in prostate cancer

    Kluth, M., Al Kilani, Z., Özden, C., Hussein, K., Frogh, S., Möller-Koop, C., Burandt, E., Steurer, S., Büscheck, F., Jacobsen, F., Luebke, A. M., Minner, S., Tsourlakis, M. C., Hoeflmayer, D., Wittmer, C., Schlomm, T., Sauter, G., Simon, R. & Wilczak, W., 08.2019, In: GENE CHROMOSOME CANC. 58, 8, p. 509-515 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Expression of the immune checkpoint receptor TIGIT in seminoma

    Hinsch, A., Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Li, W., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E., Steurer, S. & Wilczak, W., 08.2019, In: ONCOL LETT. 18, 2, p. 1497-1502 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

    Büscheck, F., Zub, M., Heumann, A., Hube-Magg, C., Simon, R., Lang, D. S., Höflmayer, D., Neubauer, E., Jacobsen, F., Hinsch, A., Luebke, A. M., Tsourlakis, M. C., Sauter, G., Huland, H., Graefen, M., Haese, A., Heinzer, H., Schlomm, T., Clauditz, T. S., Burandt, E., Wilczak, W., Steurer, S. & Minner, S., 07.2019, In: TUMOR BIOL. 41, 7, p. 1010428318824815

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. SNW1 is a prognostic biomarker in prostate cancer

    Höflmayer, D., Willich, C., Hube-Magg, C., Simon, R., Lang, D., Neubauer, E., Jacobsen, F., Hinsch, A., Luebke, A. M., Tsourlakis, M. C., Huland, H., Graefen, M., Haese, A., Heinzer, H., Minner, S., Büscheck, F., Sauter, G., Schlomm, T., Steurer, S., Clauditz, T. S., Burandt, E., Wilczak, W. & Bernreuther, C., 01.05.2019, In: DIAGN PATHOL. 14, 1, p. 33

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

    Luebke, A. M., Attarchi-Tehrani, A., Meiners, J., Hube-Magg, C., Lang, D. S., Kluth, M., Tsourlakis, M. C., Minner, S., Simon, R., Sauter, G., Büscheck, F., Jacobsen, F., Hinsch, A., Steurer, S., Schlomm, T., Huland, H., Graefen, M., Haese, A., Heinzer, H., Clauditz, T. S., Burandt, E., Wilczak, W. & Höflmayer, D., 05.2019, In: CANCER BIOL MED. 16, 2, p. 319-330 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. p53 overexpression is a prognosticator of poor outcome in esophageal cancer

    Melling, N., Norrenbrock, S., Kluth, M., Simon, R., Hube-Magg, C., Steurer, S., Hinsch, A., Burandt, E., Jacobsen, F., Wilczak, W., Quaas, A., Bockhorn, M., Grupp, K., Tachezy, M., Izbicki, J., Sauter, G. & Gebauer, F., 04.2019, In: ONCOL LETT. 17, 4, p. 3826-3834 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

    Schroeder, C., Grell, J., Hube-Magg, C., Kluth, M., Lang, D., Simon, R., Höflmayer, D., Minner, S., Burandt, E., Clauditz, T. S., Büscheck, F., Jacobsen, F., Huland, H., Graefen, M., Schlomm, T., Sauter, G. & Steurer, S., 01.03.2019, In: BMC CANCER. 19, 1, p. 193

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

    Minner, S., Lutz, J., Hube-Magg, C., Kluth, M., Simon, R., Höflmayer, D., Burandt, E., Tsourlakis, M. C., Sauter, G., Büscheck, F., Wilczak, W., Steurer, S., Schlomm, T., Huland, H., Graefen, M., Haese, A., Heinzer, H., Jacobsen, F., Hinsch, A., Poos, A., Oswald, M., Rippe, K., König, R. & Schroeder, C., 02.2019, In: PROSTATE. 79, 3, p. 302-311 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

    Mandelkow, T., Blessin, N. C., Lueerss, E., Pott, L., Simon, R., Li, W., Wellge, B., Debatin, N. F., Höflmayer, D., Izbicki, J. R., Büscheck, F., Luebke, A. M., Wittmer, C., Jacobsen, F., Lutz, F., Burandt, E., Steurer, S., Sauter, G., Tsourlakis, M. C., Wilczak, W., Hinsch, A. & Minner, S., 2019, In: DIS MARKERS. 2019, p. 2532518

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer

    Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Li, W., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E-C., Steurer, S., Wilczak, W. & Hinsch, A., 2019, In: DIS MARKERS. 2019, p. 5160565

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues

    Kind, S., Merenkow, C., Büscheck, F., Möller, K., Dum, D., Chirico, V., Luebke, A. M., Höflmayer, D., Hinsch, A., Jacobsen, F., Göbel, C., Weidemann, S., Fraune, C., Möller-Koop, C., Hube-Magg, C., Clauditz, T. S., Simon, R., Sauter, G., Wilczak, W., Bawahab, A. A., Izbicki, J. R., Perez, D. & Marx, A., 2019, In: DIS MARKERS. 2019, 4928315.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. 2018

  24. Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma

    Li, W., Blessin, N. C., Simon, R., Kluth, M., Fischer, K., Hube-Magg, C., Makrypidi-Fraune, G., Wellge, B., Mandelkow, T., Debatin, N. F., Pott, L., Höflmayer, D., Lennartz, M., Sauter, G., Izbicki, J. R., Minner, S., Büscheck, F., Uhlig, R., Dum, D., Krech, T., Luebke, A. M., Wittmer, C., Jacobsen, F., Burandt, E., Steurer, S., Wilczak, W. & Hinsch, A., 04.12.2018, In: BMC CANCER. 18, 1, p. 1209

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. High expression of class III β-tubulin in upper gastrointestinal cancer types

    Höflmayer, D., Öztürk, E., Schroeder, C., Hube-Magg, C., Blessin, N. C., Simon, R., Lang, D. S., Neubauer, E., Göbel, C., Heinrich, M-C., Fraune, C., Möller, K., Armbrust, M., Freytag, M., Hinsch, A., Lühr, C., Noack, M., Reiswich, V., Weidemann, S., Bockhorn, M., Perez, D., Izbicki, J. R., Sauter, G. & Jacobsen, F., 12.2018, In: ONCOL LETT. 16, 6, p. 7139-7145 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome

    Grupp, K., Hofmann, B., Kutup, A., Bachmann, K., Bogoevski, D., Melling, N., Uzunoglu, F. G., El Gammal, A. T., Koop, C., Simon, R., Steurer, S., Krech, T., Burdak-Rothkamm, S., Jacobsen, F., Sauter, G., Izbicki, J. & Wilczak, W., 12.11.2018, In: BMC CANCER. 18, 1, p. 1106

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Diagnostic prediction of complicated appendicitis by combined clinical and radiological appendicitis severity index (APSI)

    Avanesov, M., Wiese, N. J., Karul, M., Guerreiro, H., Keller, S., Busch, P., Jacobsen, F., Adam, G. & Yamamura, J., 09.2018, In: EUR RADIOL. 28, 9, p. 3601-3610 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer

    Wilczak, W., Wittmer, C., Clauditz, T., Minner, S., Steurer, S., Büscheck, F., Krech, T., Lennartz, M., Harms, L., Leleu, D., Ahrens, M., Ingwerth, S., Günther, C. T., Koop, C., Simon, R., Jacobsen, F., Tsourlakis, M. C., Chirico, V., Höflmayer, D., Vettorazzi, E., Haese, A., Steuber, T., Salomon, G., Michl, U., Budäus, L., Tilki, D., Thederan, I., Fraune, C., Göbel, C., Henrich, M-C., Juhnke, M., Möller, K., Bawahab, A. A., Uhlig, R., Adam, M., Weidemann, S., Beyer, B., Huland, H., Graefen, M., Sauter, G. & Schlomm, T., 09.2018, In: EUR UROL. 74, 3, p. 376-386 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

    Heumann, A., Kaya, Ö., Burdelski, C., Hube-Magg, C., Kluth, M., Lang, D. S., Simon, R., Beyer, B., Thederan, I., Sauter, G., Izbicki, J. R., Luebke, A. M., Hinsch, A., Jacobsen, F., Wittmer, C., Büscheck, F., Höflmayer, D., Minner, S., Tsourlakis, M. C., Schlomm, T. & Wilczak, W., 21.08.2018, In: SCI REP-UK. 8, 1, p. 12821

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  30. Immunohistochemically detected IDH1 mutation is rare and mostly heterogeneous in prostate cancer

    Hinsch, A., Brolund, M., Hube-Magg, C., Kluth, M., Simon, R., Möller-Koop, C., Sauter, G., Steurer, S., Luebke, A., Angerer, A., Wittmer, C., Neubauer, E., Göbel, C., Büscheck, F., Minner, S., Wilczak, W., Schlomm, T., Jacobsen, F., Clauditz, T. S., Krech, T., Tsourlakis, M. C. & Schroeder, C., 06.2018, In: WORLD J UROL. 36, 6, p. 877-882 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens

    Sauter, G., Clauditz, T., Steurer, S., Wittmer, C., Büscheck, F., Krech, T., Lutz, F., Lennartz, M., Harms, L., Lawrenz, L., Möller-Koop, C., Simon, R., Jacobsen, F., Wilczak, W., Minner, S., Tsourlakis, M. C., Chirico, V., Weidemann, S., Haese, A., Steuber, T., Salomon, G., Matiu, M., Vettorazzi, E., Michl, U., Budäus, L., Tilki, D., Thederan, I., Pehrke, D., Beyer, B., Fraune, C., Göbel, C., Heinrich, M., Juhnke, M., Möller, K., Bawahab, A. A. A., Uhlig, R., Huland, H., Heinzer, H., Graefen, M. & Schlomm, T., 05.2018, In: EUR UROL. 73, 5, p. 674-683 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

    Heumann, A., Heinemann, N., Hube-Magg, C., Lang, D. S., Grupp, K., Kluth, M., Minner, S., Möller-Koop, C., Graefen, M., Heinzer, H., Tsourlakis, M. C., Wilczak, W., Wittmer, C., Jacobsen, F., Huland, H., Simon, R., Schlomm, T., Sauter, G., Steurer, S., Lebok, P. & Hinsch, A., 05.01.2018, In: BMC CANCER. 18, 1, p. 37

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor Features: A tissue microarray study on 8,877 human cancers and normal tissues

    Burdelski, C., Jakani-Karimi, N., Jacobsen, F., Möller-Koop, C., Minner, S., Simon, R., Sauter, G., Steurer, S., Clauditz, T. S. & Wilczak, W., 01.2018, In: ONCOL REP. 39, 1, p. 3-12 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer

    Kluth, M., Volta, H., Hussein, M., Taskin, B., Frogh, S., Möller-Koop, C., Büscheck, F., Jacobsen, F., Tsourlakis, M. C., Lübke, A. M., Hinsch, A., Clauditz, T., Graefen, M., Heinzer, H., Huland, H., Minner, S., Sauter, G., Wilczak, W., Schlomm, T. & Simon, R., 2018, In: CANCER MANAG RES. 10, p. 5909-5917 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Upregulation of centromere protein F is linked to aggressive prostate cancers

    Göbel, C., Özden, C., Schroeder, C., Hube-Magg, C., Kluth, M., Möller-Koop, C., Neubauer, E., Hinsch, A., Jacobsen, F., Simon, R., Sauter, G., Michl, U., Pehrke, D., Huland, H., Graefen, M., Schlomm, T. & Luebke, A. M., 2018, In: CANCER MANAG RES. 10, p. 5491-5504 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. 2017

  37. FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy

    Tsourlakis, M. C., Eleftheriadou, A., Stender, A., Weigand, P., Grupp, K., Hube-Magg, C., Kluth, M., Schroeder, C., Steurer, S., Hinsch, A., Luebke, A., Angerer, A., Wittmer, C., Friedrich, E., Göbel, C., Büscheck, F., Heinzer, H., Graefen, M., Simon, R., Sauter, G., Wilczak, W., Minner, S., Schlomm, T. & Jacobsen, F., 07.12.2017, In: CARCINOGENESIS. 38, 12, p. 1180-1187 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer

    Burdelski, C., Shihada, R., Hinsch, A., Angerer, A., Göbel, C., Friedrich, E., Hube-Magg, C., Burdak-Rothkamm, S., Kluth, M., Simon, R., Möller-Koop, C., Sauter, G., Büscheck, F., Wittmer, C., Clauditz, T. S., Krech, T., Tsourlakis, M. C., Minner, S., Graefen, M., Schlomm, T., Wilczak, W. & Jacobsen, F., 11.2017, In: PROSTATE. 77, 15, p. 1528-1538 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers

    Person, F., Wilczak, W., Hube-Magg, C., Burdelski, C., Möller-Koop, C., Simon, R., Noriega, M., Sauter, G., Steurer, S., Burdak-Rothkamm, S. & Jacobsen, F., 10.2017, In: TUMOR BIOL. 39, 10, p. 1010428317712166

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer

    Jacobsen, F., Kraft, J., Schroeder, C., Hube-Magg, C., Kluth, M., Lang, D. S., Simon, R., Sauter, G., Izbicki, J. R., Clauditz, T. S., Luebke, A. M., Hinsch, A., Wilczak, W., Wittmer, C., Büscheck, F., Höflmayer, D., Minner, S., Tsourlakis, M. C., Huland, H., Graefen, M., Budäus, L., Thederan, I., Salomon, G., Schlomm, T. & Melling, N., 09.2017, In: NEOPLASIA. 19, 9, p. 707-715 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer

    Jacobsen, F., Taskin, B., Melling, N., Sauer, C., Wittmer, C., Hube-Magg, C., Kluth, M., Simon, R., Pehrke, D., Beyer, B., Steuber, T., Thederan, I., Sauter, G., Schlomm, T., Wilczak, W., Möller, K., Weidemann, S. A. & Burdak-Rothkamm, S., 26.07.2017, In: BMC CANCER. 17, 1, p. 504

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

    Heumann, A., Kaya, Ö., Burdelski, C., Hube-Magg, C., Kluth, M., Lang, D. S., Simon, R., Beyer, B., Thederan, I., Sauter, G., Izbicki, J. R., Luebke, A. M., Hinsch, A., Jacobsen, F., Wittmer, C., Büscheck, F., Höflmayer, D., Minner, S., Tsourlakis, M. C., Schlomm, T. & Wilczak, W., 17.05.2017, In: SCI REP-UK. 7, 1, p. 2056

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

    Burdelski, C., Borcherding, L., Kluth, M., Hube-Magg, C., Melling, N., Simon, R., Möller-Koop, C., Weigand, P., Minner, S., Haese, A., Michl, H. U., Tsourlakis, M. C., Jacobsen, F., Hinsch, A., Wittmer, C., Lebok, P., Steurer, S., Izbicki, J. R., Sauter, G., Krech, T., Büscheck, F., Clauditz, T., Schlomm, T. & Wilczak, W., 09.05.2017, In: ONCOTARGET. 8, 19, p. 31494-31508 15 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers

    Burdelski, C., Fitzner, M., Hube-Magg, C., Kluth, M., Heumann, A., Simon, R., Krech, T., Clauditz, T., Büscheck, F., Steurer, S., Wittmer, C., Hinsch, A., Luebke, A. M., Jacobsen, F., Minner, S., Tsourlakis, M. C., Beyer, B., Steuber, T., Thederan, I., Sauter, G., Izbicki, J., Schlomm, T. & Wilczak, W., 04.2017, In: NEOPLASIA. 19, 4, p. 279-287 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. MALDI imaging mass spectrometry reveals multiple clinically relevant masses in colorectal cancer using large-scale tissue microarrays

    Hinsch, A., Buchholz, M., Odinga, S., Borkowski, C., Koop, C., Izbicki, J. R., Wurlitzer, M., Krech, T., Wilczak, W., Steurer, S., Jacobsen, F., Burandt, E-C., Stahl, P., Simon, R., Sauter, G. & Schlüter, H., 03.2017, In: J MASS SPECTROM. 52, 3, p. 165-173

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. βIII-tubulin overexpression is linked to agressive tumor features and genetic instability in urinary bladder cancer

    Hinsch, A., Chaker, A., Burdelski, C., Koop, C., Tsourlakis, M. C., Steurer, S., Rink, M., Eichenauer, T. S., Wilczak, W., Wittmer, C., Fisch, M., Simon, R., Sauter, G., Büschek, F., Clauditz, T., Minner, S. & Jacobsen, F., 03.2017, In: HUM PATHOL. 61, p. 210-220

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

    Melling, N., Rashed, M., Schroeder, C., Hube-Magg, C., Kluth, M., Lang, D., Simon, R., Möller-Koop, C., Steurer, S., Sauter, G., Jacobsen, F., Büscheck, F., Wittmer, C., Clauditz, T., Krech, T., Tsourlakis, M. C., Minner, S., Huland, H., Graefen, M., Budäus, L., Thederan, I., Salomon, G., Schlomm, T. & Wilczak, W., 29.01.2017, In: INT J MOL SCI. 18, 2, p. 286

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Deletion of 8p is an independent prognostic parameter in prostate cancer

    Kluth, M., Amschler, N. N., Galal, R., Möller-Koop, C., Barrow, P., Tsourlakis, M. C., Jacobsen, F., Hinsch, A., Wittmer, C., Steurer, S., Krech, T., Büscheck, F., Clauditz, T. S., Beyer, B., Wilczak, W., Graefen, M., Huland, H., Minner, S., Schlomm, T., Sauter, G. & Simon, R., 03.01.2017, In: ONCOTARGET. 8, 1, p. 379-392 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. 2016

  50. Deletion of 18q is a strong and independent prognostic feature in prostate cancer

    Kluth, M., Graunke, M., Koop, C., Hube-Magg, C., Minner, S., Michl, U., Graefen, M., Huland, H., Pompe, R., Jacobsen, F., Hinsch, A., Wittmer, C., Lebok, P., Steurer, S., Büscheck, F., Clauditz, T., Wilczak, W., Sauter, G., Schlomm, T. & Simon, R., 27.12.2016, In: ONCOTARGET. 7, 52, p. 86339-86349 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens

    Sauter, G., Steurer, S., Clauditz, T. S., Krech, T., Wittmer, C., Lutz, F., Lennartz, M., Janssen, T., Hakimi, N., Simon, R., von Petersdorff-Campen, M., Jacobsen, F., Loga, K., Wilczak, W., Minner, S., Tsourlakis, M. C., Chirico, V., Haese, A., Heinzer, H., Beyer, B., Graefen, M., Michl, U., Salomon, G., Steuber, T., Budäus, L. H., Hekeler, E., Malsy-Mink, J., Kutzera, S., Fraune, C., Göbel, C., Huland, H. & Schlomm, T., 01.04.2016, In: EUR UROL. 69, 4, p. 592-8

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. 2015

  53. FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma

    Loga, K., Kohlhaussen, J., Burkhardt, L., Simon, R., Steurer, S., Burdak-Rothkamm, S., Jacobsen, F., Sauter, G. & Krech, T., 2015, In: PLOS ONE. 10, 11, p. e0141867

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. 2014

  55. Synchronous Ileocecal Neuroendocrine Tumor and Carotid Chemodectoma: Diagnosis by 111In Pentetreotide SPECT/CT

    Wisotzki, C., Jacobsen, F., Salamon, J. & Derlin, T., 01.06.2014, In: CLIN NUCL MED. 39, 6, p. 547-8 2 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. 2013

  57. High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer.

    Jacobsen, F., Ashtiani, S. N., Tennstedt, P., Heinzer, H., Simon, R., Sauter, G., Sirma, H., Tsourlakis, M. C., Minner, S. J. P., Schlomm, T. & Michl, U., 2013, In: EXP THER MED. 5, 1, p. 102-106 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  58. 2010

  59. Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.

    Pabst, C., Zustin, J., Jacobsen, F., Luetkens, T., Kröger, N., Schilling, G., Bokemeyer, C., Sauter, G., Atanackovic, D. & Marx, A., 2010, In: EXP MOL PATHOL. 89, 2, p. 175-181 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 Next